PEDIATRICS Vol. 122 No. 1 July 2008, pp. 8-12 (doi:10.1542/peds.2007-1192)
ARTICLE |
Long-Term Safety and Impact on Infection Rates of Postnatal Probiotic and Prebiotic (Synbiotic) Treatment: Randomized, Double-Blind, Placebo-Controlled Trial
a Department of Pediatrics, Skin and Allergy Hospital
b Department of Pediatrics, Hospital for Children and Adolescents
c Department of Pharmacology, Institute of Biomedicine, University of Helsinki, Helsinki, Finland
d STAT Consulting, Tampere, Finland
e Valio Research and Development, Helsinki, Finland
OBJECTIVE. Live probiotic bacteria and dietary prebiotic oligosaccharides (together termed synbiotics) increasingly are being used in infancy, but evidence of long-term safety is lacking. In a randomized, placebo-controlled, double-blind trial, we studied the safety and long-term effects of feeding synbiotics to newborn infants.
METHODS. Between November 2000 and March 2003, pregnant mothers carrying infants at high risk for allergy were randomly assigned to receive a mixture of 4 probiotic species (Lactobacillus rhamnosus GG and LC705, Bifidobacterium breve Bb99, and Propionibacterium freudenreichii ssp shermanii) or a placebo for 4 weeks before delivery. Their infants received the same probiotics with 0.8 g of galactooligosaccharides, or a placebo, daily for 6 months after birth. Safety data were obtained from clinical examinations and interviews at follow-up visits at ages 3, 6, and 24 months and from questionnaires at ages 3, 6, 12, and 24 months. Growth data were collected at each time point.
RESULTS. Of the 1018 eligible infants, 925 completed the 2-year follow-up assessment. Infants in both groups grew normally. We observed no difference in neonatal morbidity, feeding-related behaviors (such as infantile colic), or serious adverse events between the study groups. During the 6-month intervention, antibiotics were prescribed less often in the synbiotic group than in the placebo group (23% vs 28%). Throughout the follow-up period, respiratory infections occurred less frequently in the synbiotic group (geometric mean: 3.7 vs 4.2 infections).
CONCLUSION. Feeding synbiotics to newborn infants was safe and seemed to increase resistance to respiratory infections during the first 2 years of life.
Key Words: probiotic prebiotic synbiotic safety growth respiratory infections antibiotics
Abbreviations: GOS—galactooligosaccharide OR—odds ratio CI—confidence interval
Accepted Nov 6, 2007.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
B. Schouten, B. C. A. M. van Esch, G. A. Hofman, S. A. C. M. van Doorn, J. Knol, A. J. Nauta, J. Garssen, L. E. M. Willemsen, and L. M. J. Knippels Cow Milk Allergy Symptoms Are Reduced in Mice Fed Dietary Synbiotics during Oral Sensitization with Whey J. Nutr., July 1, 2009; 139(7): 1398 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Minocha Probiotics for Preventive Health Nutr Clin Pract, April 1, 2009; 24(2): 227 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shafai Routine Supplement of Prebiotics and Probiotics to Newborn Infants Is Not Recommended Pediatrics, March 1, 2009; 123(3): e543 - e544. [Full Text] [PDF] |
||||
![]() |
Long-Term Use of Synbiotics Is Safe Journal Watch Pediatrics and Adolescent Medicine, September 24, 2008; 2008(924): 5 - 5. [Full Text] |
||||









